Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age

NCT03633526 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped Study discontinued after Part A due to Sponsor's discretion.

Conditions

Cystic Fibrosis

Interventions

DRUG: VX-659/TEZ/IVA
DRUG: IVA

Sponsor

Vertex Pharmaceuticals Incorporated